Occult bone marrow involvement in Hodgkin's disease: Detection by magnetic resonance;Afección oculta de la médula ósea en la enfermedad de Hodgkin: Detección por resonancia magnética

Medicina Clinica

Volumn 107, Issue 4, 1996, Pages 143-145

  Sanz, Llúcia ^a   Cervantes, Francisco ^a   Mercader, Josep Maria ^b   Rozman, María ^a   Rozman, Ciril ^a,c   Montserrat, Emilio ^a  

^a Servicio de Hematología

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BONE MARROW DISEASE; CASE REPORT; HODGKIN DISEASE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

ADULT; BONE MARROW DISEASES; HODGKIN DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE;

EID: 0030597836     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Rozman M, Feliu E, Rozman C. Bone marrow biopsy in the management of Hodgkin's disease: is it useful? Hematology Review 1994; 8: 295-304.
2. Weiss RB, Brunning RD, Kennedy BJ. Hodgkin's disease in the bone marrow. Cancer 36: 2.077-2.083.
3. O'Carroll DI, McKenna RW, Brunning RD. Bone marrow manifestations of Hodgkin's disease. Cancer 1976; 38: 1.717-1.728.
4. Kaplan HS. Hodgkin's disease: Biology, treatment, prognosis. Blood 1981; 57: 813-822.
5. Bartl R, Frisch B, Burkhardt R, Huhn D, Pappenberger R. Assessment of bone marrow histology in Hodgkin's disease: correlation with clinical factors. Br J Haematol 1982; 51: 345-360.
6. Macintyre EA, Vaughan Hudson B, Linch DC, Vaughan Hudson G, Jellife AM. The value of staging bone marrow trephine biopsy in Hodgkin's disease. Eur J Haematol 1987; 39: 66-70.
7. Ellis ME, Diehl LF, Granger E, Elson E. Trephine needle biopsy in the initial staging of Hodgkin's disease: sensitivity and specificity of the Ann Arbor staging criteria. Am J Hematol 1989; 30: 115-120.
8. Shields AF, Porter BA, Churchley S, Olson DO, Appelbaum FR, Thomas ED. The detection of bone marrow involvement by lymphoma using magnetic resonance imaging. J Clin Oncol 1987; 5: 225-230.
9. Richards MA, Webb JAW, Jewell SE, Amess JAL, Wrigley PFM, Lister TA. Low field strength magnetic resonance imaging of bone marrow in patients with malignant lymphoma. Br J Cancer 1988; 57: 412-415.
10. Linden A, Zankovich R, Theissen P, Diehl V, Schicha H. Malignant lymphoma: bone marrow imaging versus biopsy. Radiology 1989; 173: 335-339.
11. Dóhner H, Gückel F, Knauf W, Semmler W, Van Kaick G, Ho AD et al. Magnetic resonance imaging of bone marrow in lymphoproliferative disorders: correlation with bone marrow biopsy. Br J Haematol 1989; 73: 12-17.
12. Smith SR, Williams ChE, Davies JM, Edwards RHT. Bone marrow disorders: characterization with quantitative M. R. imaging. Radiology 1989; 172: 805-810.
13. Smith SR, Williams CE, Edwards RHT, Davies JM. Quantitative magnetic resonance imaging in autologous bone marrow transplantation for Hodgkin's disease. Br J Cancer 1989; 60: 961-965.
14. Hoane BR, Shields AF, Porter BA, Shulman HM. Detection of lymphomatous bone marrow involvement in Hodgkin's disease by quantitative magnetic resonance imaging techniques. Blood 1991; 78: 728-738.
15. Smith SR, Roberts N. Detection of bone marrow involvement in Hodgkin's disease by quantitative magnetic resonance imaging techniques. Blood 1992; 79: 833-834.
16. Smith SR, Roberts N, Percy DF, Edwards RHT. Detection of bone marrow abnormalities in patients with Hodgkin's disease by T1 mapping of M. R. images of lumbar vertebral bone marrow. Br J Cancer 1992; 65: 246-251.